Trial Profile
A Phase I, Single-Center, Randomized, Vehicle and Active-Controlled Study to Assess and Compare the Atrophy-Causing Potential of Topical CRx-191 Formulations in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Mometasone/nortriptyline (Primary) ; Clobetasol; Mometasone; Nortriptyline
- Indications Asthma; Depression; Psoriasis
- Focus Adverse reactions
- Sponsors Zalicus
- 10 Jun 2011 New trial record